PLI in Ten Sectors Claims Rs 2.40 Private Sector Investment, Disbursals Leg

Ø  PLI Schemes Drive Over ₹15.2 Lakh Crore Exports, Strengthen Manufacturing Across Key Sectors

1.    PLI Scheme Overview

o    The Government has launched Production Linked Incentive (PLI) Schemes for 14 key sectors with an approved financial outlay of ₹1.91 lakh crore.

o    The schemes aim to strengthen manufacturing, attract investment, increase exports, generate employment and improve India's global competitiveness.

2.    Implementation Mechanism

o    The Department for Promotion of Industry and Internal Trade (DPIIT) is the nodal department for overall coordination and monitoring.

o    Individual Administrative Ministries and Departments implement their respective sectoral PLI schemes.

3.    Overall Achievements (as on 31 March 2026)

o    Actual investment: Over ₹2.40 lakh crore.

o    Employment generated: More than 14.15 lakh (direct and indirect).

4.    Export Performance

o    PLI schemes have collectively enabled exports exceeding ₹15.2 lakh crore since their inception.

o    This reflects India's increasing integration into global value chains.

Sector-wise Impact

5.    Large Scale Electronics Manufacturing

o    Mobile phone production has increased by around 2.4 times since the scheme was launched.

o    Mobile phone imports have declined by approximately 77%.

o    About 99.2% of mobile phones used in India are now manufactured domestically.

6.    Pharmaceuticals

o    Cumulative sales under the scheme have exceeded ₹3.64 lakh crore.

o    Domestic production of 1,931 pharmaceutical products has been enabled.

o    This includes 191 bulk drugs manufactured in India for the first time.

7.    Bulk Drugs

o    Manufacturing capacity of around 55,000 metric tonnes has been established across 26 critical Active Pharmaceutical Ingredients (APIs).

o    Domestic production has increased for APIs such as Paracetamol, Levofloxacin and Norfloxacin, reducing import dependence.

8.    Medical Devices

o    The scheme has facilitated domestic production of advanced medical equipment, including:

§  CT Scanners

§  MRI Systems

§  Cath Labs

§  Ultrasonography equipment.

o    22 applicants have commenced production.

o    55 unique medical devices have been commissioned.

9.    Telecom & Networking Products

o    The scheme has supported indigenous 4G technology development.

o    It has also strengthened domestic manufacturing capabilities for 5G telecom equipment.

10.  White Goods

o    Compressor manufacturing capacity increased from 1 million units in 2021 to 10 million units in 2025–26.

o    Localisation of key components such as Printed Circuit Board Assemblies (PCBAs) and Cross Flow Fans has improved significantly.

o    Domestic manufacturing of several critical air-conditioner components has expanded.

Export Growth Under PLI

11.  Rapid Increase in Exports

o    Cumulative exports under PLI schemes increased from:

§  ₹4 lakh crore (as on 31 March 2024)

§  to ₹15.2 lakh crore (as on 31 March 2026).

Monitoring and Mid-course Corrections

12.  Regular Review Mechanism

o    Implementation is periodically reviewed by:

§  The Empowered Group of Secretaries (EGoS) chaired by the Cabinet Secretary.

§  Concerned Administrative Ministries and Departments.

13.  Scheme Modifications

o    Based on stakeholder feedback and implementation experience, modifications have been made in selected schemes to address operational challenges and improve implementation.

Measures to Improve Effectiveness

14.  Government Initiatives

o    Periodic review of implementation.

o    Rationalisation of scheme guidelines.

o    Relaxation of certain eligibility conditions.

o    Strengthening of project monitoring mechanisms.

o    Regular stakeholder consultations.

o    Timely resolution of implementation issues through the Empowered Group of Secretaries (EGoS).

15.  Overall Objective

o    These measures aim to improve scheme uptake, accelerate investments, boost production and exports, create employment, and strengthen domestic manufacturing ecosystems across the 14 PLI sectors.

 

[ABS News Service/22.07.2026]

The Government has launched Production Linked Incentive (PLI) Schemes for 14 key sectors with an approved financial outlay of ₹1.91 lakh crore to enhance India's manufacturing capabilities, attract investments, increase exports, generate employment and improve India's global competitiveness. The Department for Promotion of Industry and Internal Trade (DPIIT) acts as the nodal Department for overall coordination and monitoring of the PLI Schemes, while the respective Administrative Ministries/Departments are responsible for implementation of their respective Schemes.

As on 31.03.2026, under the PLI Schemes, resulted actual investment of over ₹2.40 lakh crore and employment generation of over 14.15 lakh (direct and indirect). The sector-wise details of investments and employment generated are at Annexure-I.

The sectoral impact of the Production Linked Incentive (PLI) Schemes across various sectors is as under:

·         The PLI Schemes have collectively enabled exports of over ₹15.2 lakh crore since their inception, reflecting India's growing integration with global value chains.

·         In the Large Scale Electronics Manufacturing sector, mobile phone production has increased by around 2.4 times since the launch of the Scheme. Mobile phone imports have declined by about 77%, and around 99.2% of mobile phones used in India are now manufactured domestically.

·         The Pharmaceuticals sector has recorded cumulative sales of over ₹3.64 lakh crore under the Scheme. It has also enabled the domestic manufacture of 1,931 pharmaceutical products, including 191 bulk drugs manufactured in India for the first time, thereby strengthening domestic manufacturing capabilities.

·         In the Bulk Drugs sector, manufacturing capacity of about 55,000 MT has been established across 26 critical Active Pharmaceutical Ingredients (APIs), significantly enhancing domestic production capacity and reducing import dependence for products such as Paracetamol, Levofloxacin and Norfloxacin.

·         The PLI Scheme for Manufacturing of Medical Devices has facilitated domestic manufacturing of advanced medical equipment such as CT Scanners, MRI Systems, Cath Labs and Ultrasonography equipment. 22 applicants have commenced operations and 55 unique medical devices have been commissioned.

·         In the Telecom & Networking Products sector, the Scheme has supported the development of indigenous 4G technology and domestic manufacturing capability for 5G telecom equipment, strengthening India's telecom manufacturing ecosystem.

·         The PLI Scheme for White Goods has contributed to a significant expansion in domestic manufacturing. Compressor manufacturing capacity has increased from 1 million units in 2021 to 10 million units in 2025-26, while localisation of key components such as PCBAs and Cross Flow Fans has improved substantially, leading to domestic manufacturing of several critical air-conditioner components.

The cumulative exports reported under the Sectors of PLI Schemes have shown a steady increase over the last three years. The cumulative exports reported as on 31.03.2024 were ₹4 lakh crore, which increased to ₹15.2 lakh crore as on 31.03.2026. The year-wise details are given at Annexure-II.

The implementation of the PLI Schemes is reviewed periodically by the Empowered Group of Secretaries (EGoS), chaired by the Cabinet Secretary, as well as by the respective Administrative Ministries/Departments. Based on stakeholder feedback and implementation experience, modifications have been carried out in certain Schemes, wherever required, to address implementation challenges and facilitate effective implementation.

The Government has undertaken several measures to improve the effectiveness of the PLI Schemes. These include periodic review of Scheme implementation, rationalisation of Scheme guidelines, relaxation of certain eligibility conditions, strengthening of project monitoring mechanisms, regular

stakeholder consultations, and timely resolution of implementation issues in coordination with the concerned Ministries/Departments through the Empowered Group of Secretaries (EGoS). These measures are aimed at improving Scheme uptake, accelerating investments, enhancing production and exports, generating employment and strengthening domestic manufacturing ecosystems.

This information was given by Minister of State for Ministry of Commerce and Industry, Shri Jitin Prasada in a written reply in Lok Sabha on 21 July, 2026.

ANNEXURE-I

Sl.No.

Sectors

Cumulative Investment till March, 2026 (Rs. In crore)

Cumulative Employment till March, 2026

1

Large Scale Electronics Manufacturing - [MeitY]

20,580

1,69,249

2

IT Hardware 2.0 - [MeitY]

908

4,859

3

Bulk Drugs - [D/o Pharma]

5,070

5,226

4

Manufacturing of Medical Devices - [D/o Pharma]

1,151

5,268

5

Pharmaceuticals Drugs - [D/o Pharma]

45,158

1,14,880

6

Telecom & Networking Products - [D/o Telecom]

5,278

33,610

7

Food Products - [MoFPI]

9,207

3,29,200

8

Drones and Drone Components - [M/o Civil Aviation]*

595

2,650

9

White Goods – [DPIIT]

6,409

52,703

10

Automobiles  & Auto Components – [MHI]

44,326

67,820

11

Advance Chemistry Cell (ACC) Battery– [MHI]

4,570

1,245

12

Textile Products – [M/o Textiles]

8,117

33,427

13

Specialty Steel – [M/o Steel]

23,896

14,138

14

High Efficiency Solar PV Modules (MNRE)

64,873

14,794

 

TOTAL

2,40,138

8,49,069

* Note: Indirect employment generation of 5.66 lakhs have been reported under 3 sectors (LSEM, IT Hardwar & Solar PV Modules).

ANNEXURE-II

Financial Year

Cumulative Exports Reported under PLI Schemes

FY 2023-24

₹4.0 lakh crore

FY 2024-25

₹6.5 lakh crore

FY 2025-26

₹15.2 lakh crore